By binding to these harmful substances, it neutralizes them and aids in their safe elimination
As per FDA approval in 2021, it's indicated for chronic weight management in adults with obesity or overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes mellitus or high cholesterol (hyperlipidemia)
Patients with pre-existing renal impairment may be at higher risk, and adequate hydration should be maintained, particularly during episodes of nausea, vomiting, or diarrhea
Preclinical studies have examined the peptide in models of gastrointestinal injury, epithelial disruption, and anastomosis healing where researchers analyze mucosal architecture, vascular integrity, and epithelial continuity following tissue damage [1]
Diabetes Care 43:13521355